Philip H. Coelho - May 21, 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc. (AMPE)

Role: Director
Signature: /s/ Daniel Stokely, Attorney-in-Fact
Stock symbol: AMPE
Transactions as of: May 21, 2021
Transactions value $: -$10,779
Form type: 4
Date filed: 5/25/2021, 03:44 PM
Next filing: Aug 26, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMPE	Common Stock	Options Exercise	$2.69K	+6.74K	+3.31%	$0.40	210K	May 21, 2021	Direct	F1
transaction	AMPE	Common Stock	Sale	-$13.5K	-6.74K	-3.2%	$2.00^*	204K	May 21, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMPE	Stock Option (Right to Buy)	Options Exercise	$0	-6.74K	-100%	$0.00^*	0	May 21, 2021	Common Stock	6.74K	$0.40	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 30, 2021.
F2	Options were granted and previously reported on a Form 4 filed on January 9, 2019, where the stock option vested and became exercisable in 12 equal monthly installments from the date of grant of December 15, 2018.